Technical Analysis for BBI - Brickell Biotech, Inc.

Grade Last Price % Change Price Change
F 0.84 -4.55% -0.04
BBI closed down 4.55 percent on Thursday, April 15, 2021, on 48 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical BBI trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -4.55%
Older End-of-Day Signals for BBI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Outside Day about 23 hours ago
Down 3% about 23 hours ago
Down 2 % about 23 hours ago
Fell Below Previous Day's Low about 23 hours ago
60 Minute Opening Range Breakdown 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of various prescription therapeutics for the treatment of debilitating skin diseases in the United States. The company's lead products candidate is sofpironium bromide that is in Phase III clinical trial for patients with axillary hyperhidrosis. It is also developing therapeutics for cutaneous T-cell lymphoma, psoriasis, and other dermatological conditions. The company was founded in 2009 and is based in Boulder, Colorado.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Organ Systems Lymphoma Psoriasis Stage Pharmaceutical Skin Diseases Cutaneous T Cell Lymphoma Hyperhidrosis

Is BBI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.61
52 Week Low 0.466
Average Volume 2,780,197
200-Day Moving Average 0.93
50-Day Moving Average 1.22
20-Day Moving Average 1.10
10-Day Moving Average 1.02
Average True Range 0.09
ADX 16.09
+DI 15.02
-DI 32.09
Chandelier Exit (Long, 3 ATRs ) 1.12
Chandelier Exit (Short, 3 ATRs ) 1.11
Upper Bollinger Band 1.35
Lower Bollinger Band 0.86
Percent B (%b) -0.05
BandWidth 43.80
MACD Line -0.08
MACD Signal Line -0.05
MACD Histogram -0.0281
Fundamentals Value
Market Cap 44.95 Million
Num Shares 53.5 Million
EPS -9.55
Price-to-Earnings (P/E) Ratio -0.09
Price-to-Sales 3.81
Price-to-Book 1.87
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.95
Resistance 3 (R3) 0.96 0.93 0.93
Resistance 2 (R2) 0.93 0.91 0.93 0.92
Resistance 1 (R1) 0.89 0.89 0.88 0.88 0.92
Pivot Point 0.86 0.86 0.86 0.86 0.86
Support 1 (S1) 0.82 0.84 0.81 0.81 0.76
Support 2 (S2) 0.79 0.82 0.79 0.76
Support 3 (S3) 0.75 0.79 0.75
Support 4 (S4) 0.74